CV Sciences, Inc.
CVSI · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.10 | -0.05 | 0.16 | -0.04 |
| FCF Yield | 0.00% | 3.49% | -2.03% | -2.92% |
| EV / EBITDA | -29.88 | -101.70 | 71.84 | -10.60 |
| Quality | ||||
| ROIC | -9.46% | -3.50% | 0.34% | -24.58% |
| Gross Margin | 0.00% | 50.94% | 45.98% | 43.18% |
| Cash Conversion Ratio | – | -1.10 | 0.74 | 0.23 |
| Growth | ||||
| Revenue 3-Year CAGR | -11.58% | -1.63% | -1.27% | -1.04% |
| Free Cash Flow Growth | -100.00% | 296.69% | 33.52% | -49.18% |
| Safety | ||||
| Net Debt / EBITDA | -1.74 | -8.30 | 7.65 | -0.53 |
| Interest Coverage | -2.57 | -1.01 | 0.07 | -6.87 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.42 | 0.45 | 0.45 |
| Cash Conversion Cycle | 0.00 | 154.23 | 143.42 | 133.29 |